摘要
Prostate-only radiotherapy(PORT) is widely used as the definitive treatment for localized prostate cancer.Prostate cancer has an α/β ratio;therefore,radiotherapy(RT) with a large fraction size is biologically effective for tumor control.The current external beam RT technique for PORT has been improved from threedimensional conformal RT to intensity-modulated,stereotactic body,and imageguided RTs.These methods are associated with reduced radiation exposure to normal tissues,decreasing urinary and bowel toxicity.Several trials have shown improved local control with dose escalation through the aforementioned methods,and the efficacy and safety of intensity-modulated and stereotactic body RTs have been proven.However,the management of RT in patients with prostate cancer has not been fully elucidated.As a clinician,there are several concerns regarding the RT volume and dose considering the patient’s age and comorbidities.Therefore,this review aimed to discuss the radiobiological basis and external beam technical advancements in PORT for localized prostate cancer from a clinician’s perspective.
